Edesa Biotech, Inc. (EDSA) Balance Sheet
EDSA balance sheet, FY2025
September 30, 2025 · U.S. dollars$13.5M assets = $1.1M liabilities + $12.5M equity
Both columns are drawn to the same scale: what EDSA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
EDSA financial health
Equity / assets92.0%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles14.6%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal FY2025.
EDSA balance sheet trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $12.9MFY2016 | $13.5MFY2025 | +0.5%/yr | |
| Total liabilities | $623,644FY2016 | $1.1MFY2025 | +6.3%/yr | |
| Shareholders’ equity | $12.3MFY2016 | $12.5MFY2025 | +0.1%/yr | |
| Cash & short-term investments | $11.4MFY2016 | $10.8MFY2025 | −0.6%/yr | |
| Total debt | $164,189FY2020 | $19,867FY2024 | −41.0%/yr | |
| Net cash (debt) | $7.0MFY2020 | $1.0MFY2024 | −$6.0M | |
| Working capital | $11.5MFY2016 | $10.4MFY2025 | −$1.0M | |
| Book value per share | $2.47FY2023 | $2.19FY2025 | −5.7%/yr | |
| Debt / equity | 0.02FY2020 | 0.01FY2024 | −0.01 | |
| Shares outstanding | 2.9MFY2023 | 5.7MFY2025 | +40.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
EDSA assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
EDSA liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
EDSA debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
EDSA balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $10.8M | $1.0M | $5.4M | $7.1M | $7.8M | $7.2M | $5.0M | $10.3M | $6.6M | $11.4M |
| Cash & equivalents | $10.8M | $1.0M | $5.4M | $7.1M | $7.8M | $7.2M | $5.0M | $4.2M | $4.6M | $7.4M |
| Short-term investments | — | — | — | — | — | — | — | $6.1M | $2.0M | $4.0M |
| Receivables | $642,866 | $270,908 | $626,543 | $1.3M | $3.3M | $87,446 | $217,101 | $41,246 | $1,287 | $85,813 |
| Inventory | $0 | $0 | $0 | −$1.3M | $0 | −$87,446 | −$217,101 | $224,267 | $68,114 | $249,430 |
| Other current assets | $77,838 | $367,394 | $448,912 | $2.0M | $948,645 | $890,323 | $614,123 | $86,919 | $123,694 | $358,714 |
| Total current assets | $11.5M | $1.7M | $6.4M | $9.1M | $12.1M | $8.1M | $5.6M | $10.7M | $6.8M | $12.1M |
| Property, plant & equipment (net) | $0 | $18,361 | $100,075 | $31,159 | $111,560 | $174,821 | $73,058 | $1.1M | $879,523 | $756,114 |
| Goodwill & intangible assets | $2.0M | $2.1M | $2.2M | $2.3M | $2.4M | $2.5M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $46,456 | $66,695 | $66,695 |
| Other non-current assets | $39,966 | $41,151 | $173,490 | $171,464 | $0 | $0 | $0 | $15,340 | $15,340 | $15,340 |
| Total assets | $13.5M | $3.8M | $8.9M | $11.6M | $14.6M | $10.8M | $5.7M | $11.8M | $7.7M | $12.9M |
| Liabilities | ||||||||||
| Accounts payable | $1.1M | $1.8M | $1.7M | $2.1M | $1.4M | $1.5M | $424,634 | $493,385 | $320,947 | $623,644 |
| Short-term debt | — | $19,867 | $74,714 | $18,975 | $78,808 | $69,730 | — | — | — | — |
| Deferred revenue | — | — | −$1,747 | −$2.1M | −$1.4M | −$1,460 | — | — | — | — |
| Total current liabilities | $1.1M | $1.8M | $1.8M | $2.1M | $1.5M | $1.5M | $461,634 | $493,385 | $320,947 | $623,644 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $19,867 | $94,487 | $18,975 | $99,320 | $164,190 | — | — | — | — |
| Other long-term liabilities | $131,000 | $126,000 | $19,773 | $43,662 | $67,714 | $124,387 | $0 | $0 | $0 | $0 |
| Total liabilities | $1.1M | $1.8M | $1.8M | $2.2M | $1.5M | $1.7M | $461,634 | $493,385 | $320,947 | $623,644 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $54.5M | $47.2M | $46.6M | $42.5M | $34.9M | $18.5M | $12.0M | $56.7M | $48.4M | $47.3M |
| Retained earnings (deficit) | −$65.9M | −$58.6M | −$52.4M | −$44.0M | −$26.5M | −$13.1M | −$6.7M | −$50.4M | −$45.4M | −$40.4M |
| Accumulated other comprehensive income | −$165,771 | −$242,613 | −$214,648 | −$213,602 | −$205,262 | −$287,204 | −$342,074 | $5.1M | $4.4M | $5.4M |
| Total shareholders' equity | $12.5M | $2.0M | $7.0M | $9.4M | $13.1M | $9.1M | $5.3M | $11.3M | $7.4M | $12.3M |
| Key figures | ||||||||||
| Total debt | — | $19,867 | $94,487 | $18,975 | $99,320 | $164,189 | — | — | — | — |
| Net cash (debt) | — | $1.0M | $5.3M | $7.1M | $7.7M | $7.0M | — | — | — | — |
| Working capital | $10.4M | −$157,205 | $4.6M | $7.0M | $10.6M | $6.6M | $5.2M | $10.2M | $6.4M | $11.5M |
| Tangible book value | $10.5M | −$97,693 | $4.9M | $7.1M | $10.7M | $6.6M | $5.3M | $11.3M | $7.4M | $12.3M |
| Book value per share | $2.19 | $0.62 | $2.47 | — | — | — | — | — | — | — |
| Shares outstanding | 5.7M | 3.2M | 2.9M | — | — | — | — | — | — | — |
| Current ratio | 10.67 | 0.91 | 3.53 | 4.25 | 8.29 | 5.30 | 12.23 | 21.60 | 21.06 | 19.40 |
| Quick ratio | 10.60 | 0.71 | 3.29 | 3.90 | 7.64 | 4.77 | 11.37 | 20.97 | 20.46 | 18.43 |
| Debt / equity | — | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | — | — | — | — |
| Equity / assets | 92.0% | 51.9% | 79.3% | 81.1% | 89.5% | 84.6% | 91.9% | 95.8% | 95.8% | 95.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $10.3M | $10.0M | $12.1M | $10.8M | $12.4M | $13.9M | $1.6M | $1.0M | $2.0M | $2.8M | $4.3M | $5.4M |
| Cash & equivalents | $10.3M | $10.0M | $12.1M | $10.8M | $12.4M | $13.9M | $1.6M | $1.0M | $2.0M | $2.8M | $4.3M | $5.4M |
| Receivables | $228,051 | $216,468 | $431,325 | $642,866 | $286,743 | $382,440 | $350,639 | $270,908 | $551,064 | $1.1M | $743,569 | $626,543 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $0 | $0 | −$1.1M |
| Other current assets | $219,707 | $197,576 | $234,414 | $77,838 | $112,659 | $108,199 | $157,787 | $367,394 | $454,685 | $330,267 | $404,903 | $1.5M |
| Total current assets | $10.8M | $10.4M | $12.7M | $11.5M | $12.8M | $14.4M | $2.1M | $1.7M | $3.0M | $4.2M | $5.4M | $6.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $18,361 | $36,286 | $62,337 | $83,073 | $100,075 |
| Goodwill & intangible assets | $1.9M | $1.9M | $2.0M | $2.0M | $2.0M | $2.0M | $2.1M | $2.1M | $2.1M | $2.1M | $2.2M | $2.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $39,120 | $39,921 | $40,572 | $170,966 | $40,739 | $38,748 | $38,698 | $41,151 | $40,661 | $41,067 | $177,731 | $406,490 |
| Total assets | $12.7M | $12.4M | $14.7M | $13.7M | $14.8M | $16.5M | $4.2M | $3.8M | $5.2M | $6.5M | $7.8M | $9.1M |
| Liabilities | ||||||||||||
| Accounts payable | — | — | $756,163 | — | $672,674 | $914,701 | $1.9M | $1.8M | $2.3M | $2.1M | $1,909 | $1,747 |
| Short-term debt | — | — | — | — | — | — | — | $19,867 | $38,817 | $58,143 | $78,314 | $74,714 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$2.3M | −$2.1M | −$1,909 | −$1,747 |
| Total current liabilities | $3.9M | $2.2M | $756,163 | $1.1M | $672,674 | $914,701 | $1.9M | $1.8M | $2.4M | $2.2M | $2.0M | $1.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | $0 | $0 | $0 | $0 | $19,867 | $38,817 | $58,143 | $78,314 | $94,487 |
| Other long-term liabilities | $0 | $0 | $0 | $131,000 | $0 | $0 | $0 | $126,000 | $0 | $0 | $0 | $252,773 |
| Total liabilities | $3.9M | $2.2M | $756,163 | $1.2M | $672,674 | $914,701 | $1.9M | $1.8M | $2.4M | $2.2M | $2.0M | $2.1M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $62.4M | $58.9M | $57.9M | $54.5M | $54.3M | $54.3M | $47.6M | $47.2M | $47.2M | $47.1M | $46.9M | $46.6M |
| Retained earnings (deficit) | −$77.9M | −$72.5M | −$68.2M | −$65.9M | −$63.6M | −$61.9M | −$60.2M | −$58.6M | −$57.6M | −$56.0M | −$54.1M | −$52.4M |
| Accumulated other comprehensive income | −$158,541 | −$186,089 | −$171,086 | −$165,771 | −$123,077 | −$287,688 | −$223,957 | −$242,613 | −$224,791 | −$226,403 | −$215,220 | −$214,648 |
| Total shareholders' equity | $8.8M | $10.2M | $14.0M | $12.5M | $14.1M | $15.5M | $2.3M | $2.0M | $2.9M | $4.3M | $5.8M | $7.0M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | — | — | — | $19,867 | $38,817 | $58,143 | $78,314 | $94,487 |
| Net cash (debt) | — | — | — | — | — | — | — | $1.0M | $2.0M | $2.7M | $4.2M | $5.3M |
| Working capital | $6.9M | $8.2M | $12.0M | $10.4M | $12.1M | $13.5M | $171,709 | −$157,205 | $686,007 | $2.1M | $3.4M | $4.6M |
| Tangible book value | $6.9M | $8.3M | $12.0M | $10.5M | $12.1M | $13.5M | $210,407 | −$97,693 | $762,954 | $2.2M | $3.7M | $4.9M |
| Book value per share | $0.98 | $1.19 | $1.75 | $1.77 | $2.01 | $2.93 | $0.68 | $0.61 | $0.89 | $1.35 | $1.87 | $2.33 |
| Shares outstanding | 9.0M | 8.5M | 8.0M | 7.1M | 7.0M | 5.3M | 3.3M | 3.2M | 3.2M | 3.2M | 3.1M | 3.0M |
| Current ratio | 2.76 | 4.76 | 16.82 | 10.67 | 18.97 | 15.73 | 1.09 | 0.91 | 1.29 | 1.97 | 2.73 | 3.53 |
| Quick ratio | 2.70 | 4.67 | 16.51 | 10.60 | 18.80 | 15.61 | 1.01 | 0.71 | 1.10 | 1.82 | 2.52 | 3.29 |
| Debt / equity | — | — | — | — | — | — | — | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity / assets | 69.3% | 82.3% | 94.9% | 91.1% | 95.5% | 94.4% | 54.4% | 51.9% | 54.8% | 66.8% | 74.6% | 77.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 12, 2025); data from EODHD.
EDSA financial position
At the end of fiscal 2025 (September 30, 2025), Edesa Biotech had total assets of $13.5 million (up 254.8% from a year earlier), total liabilities of $1.1 million and shareholders' equity of $12.5 million. Its current ratio was 10.67. In the latest quarter (ended June 30, 2026) total assets were $12.7 million and equity $8.8 million.
Related: EDSA income statement, EDSA cash flow statement, EDSA key metrics. See the EDSA stock overview for the latest quote and news.
EDSA balance sheet FAQ
What are Edesa Biotech's total assets?
Edesa Biotech reported total assets of $13.5 million at the end of fiscal 2025 (September 30, 2025), compared with $3.8 million a year earlier.
How much cash does Edesa Biotech have?
Edesa Biotech held $10.8 million in cash and short-term investments at the end of fiscal 2025.
What is Edesa Biotech's book value?
Edesa Biotech's shareholders' equity (book value) was $12.5 million at the end of fiscal 2025, or $2.19 per share.
What is Edesa Biotech's current ratio?
Edesa Biotech had current assets of $11.5 million and current liabilities of $1.1 million, a current ratio of 10.67 (it can cover its short-term obligations).
How much goodwill does Edesa Biotech have?
Edesa Biotech carried $2.0 million of goodwill and intangible assets, 14.6% of total assets, at the end of fiscal 2025.